SYSTEMIC ENZYME THERAPY

Enzymes have long been understood because of their importance in digesting food. They also play a vital role in maintaining health by breaking up circulating immune complexes and controlling the amount of fibrin deposited in wounds, fractures and joints. Necrotic debris and excess fibrin in the blood stream are digested by enzymes. Immune system regulation is accomplished by enzymes.

When a proteolytic enzyme is present in an enzyme formulation dissolution of fibrin occurs. Over time these enzymes can actually digest unwanted scar tissue. Many diseases in humans are associated with inflammatory reactions and scarring. Because both these conditions can be corrected by enzyme therapy there is great potential for improving health using systemic enzyme therapy. Among the conditions enzymes help are:

Infections Viruses can be made inert by enzyme action. Preventing inflammation speeds up recovery from sinusitis, bronchitis, and colds.

Malignancies Tumor cells are surrounded by a layer of fibrin 15 times greater than the fibrin which surrounds healthy cells. The fibrin coating enables cancer cells to escape killing by phagocytes, killer lymphocytes, and cytokines. Enzymes dissolve this coating improving survival in cancer.

Arteriosclerosis Excessive clotting and inflammation are routine in the developing arterial plaques. Enzyme therapy digests the fibrin and reverses the inflammation which results in decreasing the size of the artery obstructing plaques. Symptoms of angina, impaired blood flow to the brain, and poor circulation to the legs often disappear.

Allergic Diseases Hay fever, asthma, and urticaria (hives) are all associated with inflammation which increases the symptoms. Enzymes not only reverse this but regular use of low doses of enzymes may prevent symptoms from reappearing.

Painful Conditions (Trauma) Enzymes can block the release of pain producing amines from tissues that are becoming inflammed. This means that early use of large doses of enzymes in broken bones, dislocated joints, sunburn, dental extractions, injuries, and migraine headaches have the capability of preventing swelling and pain from appearing.

Estrogen Excess Disorders Several health problems experienced by females are related to excessive production of estrogen (fibrocystic disease of the breast, fibroids of the uterus). Enzyme therapy helps both these conditions. Endometriosis causes a profound painful inflammatory reaction that results in scarring and sterility. This scarring and pain can be prevented by early use of enzymes.

Keloids Some individuals develop greatly enlarged unsightly scars which can be prevented and dissolved with enzymes.

Lung Diseases Scarring of the delicate alveolar membranes vital to transfer of carbon dioxide for oxygen leads to pulmonary fibrosis. Sarcoidosis can produce widespread scarring in lung tissue. Both these disorders and many other lung diseases should be helped by enzyme therapy.

Arthritic Diseases All joint diseases manifest swelling and pain. (osteoarthritis, rheumatoid arthritis, bursitis) which enzymes can alleviate. Systemic lupus erythematosus has circulating immune complexes and scleroderma has extensive scarring both of which respond to enzymes. Fibromyalgia patients have recovered using enzymes probably because of improving blood flow in the painful areas..

Kidney Diseases Glomerulonephritis (Bright’s Disease) has circulating immune complexes and inflammation in the kidney which should improve with enzymes. Inflammation is a prominent feature of most kidney diseases which suggests enzymes could be beneficial.

Arteriosclerosis Inflammation plays a key role in causing artery plaques to appear. There is also a tendency to excessive clotting. Both these problems can be reversed by systemic enzymes permitting the existing plaques to slowly disappear with disappearance of symptoms (angina, exertional leg pain, brain dysfunction from poor blood flow).

We Recommend Vitazym. | Click here to view product details >>

Vitalzym contains serrapeptase, protease, papain, bromelain, amylase, lipase, rutin and amia which is a rich source of Vitamin C. Serrapeptase is an enzyme derived from the non-pathogenic enterobacteria Serratia E 15 that has superior anti-inflammatory action¹ when compared to other proteolytic enzymes.The intestine of the silkworm contains serrapeptase which permits the silkworm to break out of its cocoon. Serrapeptase has anti-inflammatory, anti-edema, and fibrinolytic (fibrin dissolving) properties. A study in otolaryngological patients from many centers in Italy disclosed that serrapeptase was very effective in alleviating thick infected secretions². Ninety-seven percent of those taking serrapeptase reported good or excellent results compared to twenty two percent in control subjects. Knee cartilage operations were followed by 50 % less swelling³. Patients with fibrocystic breast pain⁴ reported 85 % improvement with serrapeptase (Danzen) when compared to 65 % in those not receiving serrapeptase. Twenty patients (average age 39) with carpal tunnel syndrome⁵ were given 10 mg. of serrapeptase twice daily. Thirteen of these were better with electrophysiological proof of recovery.

Rutin is a bioflavinoid which composes 4 to 6 % of buckwheat. Rutin strengthens and controls the permeability of blood vessels and capillary walls. This turns weak blood vessels into strong ones that are less likely to bleed. Rutin lowers the blood pressure and slows aging. The anti-oxidant activity in rutin combats the free radicals believed to cause 90 % of diseases (cancer, arteriosclerosis, arthritis, aging etc).

Enzyme therapy has been developed and extensively used in the Far East and Europe. This makes systemic enzyme therapy not very well known in the U.S. We think that persons who are willing to try enzymes for infections, malignancies, allergies, acute traumatic disorders, fibrotic lung diseases, arthritic diseases, kidney diseases, estrogenic problems, arteriosclerosis, and keloids are in for a pleasant surprise.

Enzymes do not cause any side effects even in very high dosage. Patients with acute problems that are associated with swelling and pain must immediately take high doses of enzymes which will prevent pain and swelling from appearing (multiple fractures from injury, dislocated hips and shoulders, sunburn, etc.). It is much easier to decrease the dosage from 15 or 20 tablets three times daily that it is to increase the dosage when pain and swelling have already appeared.

Effective systemic enzymes like Vitalzym make blood less likely to clot. This brings relief from symptoms for patients with narrowed arteries (anginal pain and claudication leg pain) but it also makes patients with hemophilia or those on anti-coagulant drugs more likely to bleed. Hemophiliacs and anti-coagulated patients must avoid systemic enzyme therapy.

You can expect prompt improvement when using enzyme therapy. If no changes are noted the dose should be increased.

The usual starting dose with Vitalzym would be 3 tablets three times daily. If there is no response in 10 to 14 days increase the dose to 4 tablets three times daily and continue to increase the dosage until a favorable change is apparent. Serious injuries need large dosage at once (15 or 20 tablets three times daily).

You should expect to see improvement when the necessary dosage has been reached. Regular use of low doses of Vitalzym (I tablet three times daily) will often help allergic individuals ward off attacks of asthma and hay fever.

We think that the usage of systemic enzymes has the potential to explode as more patients try them and realize their efficacy and safety. The lack of side effects makes them unique among therapeutic agents.

Inflammation and scarring are fundamental parts of the pathological changes seen in diseases. The ability to stop and reverse these processes is the reason enzymes have such value in a wide variety of conditions.

We think that having a bottle of Vitalzym in your home will be a great blessing when injuries, infections and allergies show up.

1. Mazzone A. et al Evaluation of serratia peptidase in acute and chronic inflammmation of otolaryngology pathology: a multicenter double-blind, randomized trial versus placebo j Int Med Res 1990:379-88

2. See above.

3. Esch PM et al Reduction of postoperative swelling Objective measurement of the upper ankle joint in trwatment with serrapeptase—a prospective study (German) Fortschr Med 1989, 107(4) 67-8. 71-2

4. Kee WH et al The treatment of breast engorgement with serrapeptase (DANZEN) a randomized double-blind controlled trial Singapore MJ (1):48-54

5. Panaguriya A et al A preliminary trial of serrapeptase in patients with carpal tunnel syndrome J Assoc Physician India 1999 Dec; 47 (12): 1170-72